Logos Global Management »

Aeglea Biotherapeutics shares owned by Logos Global Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Logos Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 150k 21.52
2023-09-30 $2.6M 210k 12.25